AstraZeneca’s coronavirus vaccine suffered a setback that shows why Big Pharma would rather be safe than sorry. Here’s the good news.

2020-09-09

  U.K.-based pharmaceutical giant AstraZeneca said Tuesday it will suspend clinical trials of a coronavirus vaccine it developed with Oxford University after a British subject fell ill. The decision will affect the company’s just-started so-called Phase 3 trial, which recruited 30,000 volunteers in the U.S. after 10,000 subjects in theRead More →

European stocks aim for a positive finish to the week

2020-06-19

European stocks pushed higher on Friday and headed for a weekly gain after days of worries over rising coronavirus cases in parts of the world. Potential good news on the U.S.-China trade front was driving some momentum. The Stoxx Europe 600 index SXXP, +0.45% rose 0.6%, after closing down 0.7%Read More →